Variant · Deletion Cna
PTEN Deletion
CI-VAR-00000630Explore in graph →CIViC 213
Curated evidence
Evidence by cancer (5 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 17700571
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Prostate Neoplasm3 | ||||||||
| PTEN Deletion | (prognostic) | Prognostic | B | Supports Poor Outcome | 4 | rejected | EID643PTEN Loss (by FISH) is associated with poorer prognosis in patients with prostate cancer. PMID 17700571 · Yoshimoto et al., 2007 · Open in CIViC | civic |
| PTEN Deletion | (prognostic) | Prognostic | B | Supports Poor Outcome | 4 | accepted | EID1741A meta-analysis of 26 published studies including 8097 prostate cancer patients showed that, compared to patients with normal PTEN, patients with PTEN deletion exhibited a greater aggressive Gleason s… (full text at CIViC) PMID 27470558 · Gao et al., 2016 · Open in CIViC | civic |
| PTEN Deletion | Everolimus | |||||||
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available